35 related articles for article (PubMed ID: 35325958)
1. MLH1, MSH2, MRE11, and XRCC1 in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
Donís SP; González AP; Alves MGO; do Carmo Carvalho BF; Ferreira CCP; Almeida JD; Iruegas EP; Petronacci CMC; Peñaranda JMS; Sayáns MP
Appl Immunohistochem Mol Morphol; 2021 Sep; 29(8):613-618. PubMed ID: 33734109
[TBL] [Abstract][Full Text] [Related]
2. Oral leukoplakia classification and staging system with incorporation of differentiated dysplasia.
Brouns ER; Evren I; Wils LJ; Poell JB; Brakenhoff RH; Bloemena E; de Visscher JGAM
Oral Dis; 2023 Oct; 29(7):2667-2676. PubMed ID: 35765231
[TBL] [Abstract][Full Text] [Related]
3. Implication of TIPE2 Expression on the Malignant Transformation of Oral Leukoplakia.
Chen H; Pei M; Shin SW; Moon S; Nam W; Zheng Z
Anticancer Res; 2023 Nov; 43(11):4937-4946. PubMed ID: 37909982
[TBL] [Abstract][Full Text] [Related]
4. Salivary metabolomics for oral leukoplakia with and without dysplasia.
Kitabatake K; Ishikawa S; Sugimoto M; Enomoto A; Kaneko M; Ota S; Edamatsu K; Yusa K; Hemmi T; Okuyama N; Iino M
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101618. PubMed ID: 37659754
[TBL] [Abstract][Full Text] [Related]
5. Deep learning-based pathology image analysis predicts cancer progression risk in patients with oral leukoplakia.
Zhang X; Gleber-Netto FO; Wang S; Martins-Chaves RR; Gomez RS; Vigneswaran N; Sarkar A; William WN; Papadimitrakopoulou V; Williams M; Bell D; Palsgrove D; Bishop J; Heymach JV; Gillenwater AM; Myers JN; Ferrarotto R; Lippman SM; Pickering CR; Xiao G
Cancer Med; 2023 Mar; 12(6):7508-7518. PubMed ID: 36721313
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Total and Lipid Bound Sialic Acid in Serum in Oral Leukoplakia.
Krishnan K; Balasundaram S
J Clin Diagn Res; 2017 Mar; 11(3):ZC25-ZC27. PubMed ID: 28511503
[TBL] [Abstract][Full Text] [Related]
7. The value of regular follow-up of oral leukoplakia for early detection of malignant transformation.
Evren I; Najim AM; Poell JB; Brouns ER; Wils LJ; Peferoen LAN; Brakenhoff RH; Bloemena E; van der Meij EH; de Visscher JGAM
Oral Dis; 2023 Nov; ():. PubMed ID: 37936517
[TBL] [Abstract][Full Text] [Related]
8. Decreased inflammatory profile in oral leukoplakia tissue exposed to cold physical plasma ex vivo.
Seebauer C; Freund E; Dieke T; Hasse S; Segebarth M; Rautenberg C; Metelmann HR; Bekeschus S
J Oral Pathol Med; 2023 Nov; 52(10):1021-1028. PubMed ID: 37827138
[TBL] [Abstract][Full Text] [Related]
9. Malignant transformation rate of oral leukoplakia in the past 20 years: A systematic review and meta-analysis.
Guan JY; Luo YH; Lin YY; Wu ZY; Ye JY; Xie SM; Li J
J Oral Pathol Med; 2023 Sep; 52(8):691-700. PubMed ID: 37224426
[TBL] [Abstract][Full Text] [Related]
10. Malignant transformation of oral leukoplakia: Systematic review and meta-analysis of the last 5 years.
Aguirre-Urizar JM; Lafuente-Ibáñez de Mendoza I; Warnakulasuriya S
Oral Dis; 2021 Nov; 27(8):1881-1895. PubMed ID: 33606345
[TBL] [Abstract][Full Text] [Related]
11. [The expression and clinical significance of Bmi-1 gene in oral leukoplakia with different prognosis].
Wu XB; Wang RY; Gong SR; Zhu J; Zhu S
Zhonghua Yi Xue Za Zhi; 2022 Mar; 102(11):787-794. PubMed ID: 35325958
[No Abstract] [Full Text] [Related]
12. The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.
Xia RH; Song XM; Wang XJ; Li J; Mao L
PLoS One; 2013; 8(6):e66794. PubMed ID: 23826135
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase 3 contributes to malignant transformation of oral leukoplakia to cancer.
Wu X; Wang R; Jiao J; Li S; Yu J; Yin Z; Zhou L; Gong Z
Int J Biochem Cell Biol; 2018 Nov; 104():34-42. PubMed ID: 30172723
[TBL] [Abstract][Full Text] [Related]
14. EZH2 promotes malignant phenotypes and is a predictor of oral cancer development in patients with oral leukoplakia.
Cao W; Younis RH; Li J; Chen H; Xia R; Mao L; Chen W; Ren H
Cancer Prev Res (Phila); 2011 Nov; 4(11):1816-24. PubMed ID: 21697275
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
